subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069

object_name: Childhood Non-Hodgkin Lymphoma

tested_intervention: unsure


subject: CHEBI:71013

subject_name: Perampanel

object_name: grade III glioma

tested_intervention: yes


subject: CHEBI:71013

object_name: grade II glioma


subject: CHEBI:71013

object_name: Drug Resistant Epilepsy


subject: CHEBI:71013

object_name: malignant glioma


subject: CHEBI:474053

subject_name: Cefazolin

object_name: prostate carcinoma


subject: CHEBI:474053

object_name: prostate cancer


subject: CHEBI:2639

subject_name: Amiloride

object_name: genetic hypertension


subject: CHEBI:2639

object_name: essential hypertension


subject: CHEBI:2639

object_name: excess; salt


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: end stage renal failure


subject: CHEBI:28787

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: Acute bacterial skin and skin structure infection


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: emphysema


subject: UNII:73B0K5S26A

object_name: chronic obstructive pulmonary disease


subject: MESH:C000620234


subject: MESH:C000620234

object_name: glioblastoma


subject: MESH:C000620234

object_name: Brain Stem Glioblastoma


subject: MESH:C000620234

object_name: glioma susceptibility 1


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UNII:52CMI0WC3Y

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:52CMI0WC3Y

object_name: Metastatic Lip and Oral Cavity Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Pharyngeal Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Sinonasal Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:52CMI0WC3Y

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:52CMI0WC3Y

object_name: Recurrent Pharyngeal Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Nasal Cavity Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:52CMI0WC3Y

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Squamous Cell Carcinoma of the Nasopharynx


subject: UNII:52CMI0WC3Y

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:52CMI0WC3Y

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C3827082

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UMLS:C3827082

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UMLS:C3827082

object_name: Metastatic Lip and Oral Cavity Carcinoma


subject: UMLS:C3827082

object_name: Metastatic Pharyngeal Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Metastatic Sinonasal Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C3827082

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C3827082

object_name: Recurrent Pharyngeal Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Metastatic Nasal Cavity Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UMLS:C3827082

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UMLS:C3827082

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C3827082

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Metastatic Squamous Cell Carcinoma of the Nasopharynx


subject: UMLS:C3827082

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C3827082

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C3827082

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C3827082

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C3827082

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C3827082

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C3827082

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v8


subject: UMLS:C3827082

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UNII:2S9ZZM9Q9V

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Lip and Oral Cavity Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Pharyngeal Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Sinonasal Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Pharyngeal Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Nasal Cavity Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Squamous Cell Carcinoma of the Nasopharynx


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UMLS:C0020852

subject_name: immunoglobulin G

object_name: myasthenia gravis


subject: UMLS:C0020852

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:8389

subject_name: conjugated estrogens

object_name: EXCESS LMW-DNA


subject: CHEBI:17474

subject_name: Estrone sulfate


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6931

subject_name: Midazolam

object_name: Failed moderate sedation during procedure


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:119915

subject_name: Fentanyl


subject: UNII:JKP2Z098S2

object_name: atopic eczema


subject: UMLS:C3886691


subject: UMLS:C2716992

subject_name: antitumor A

object_name: lung cancer


subject: UMLS:C2716992

object_name: lung neoplasm


subject: UMLS:C2716992

object_name: lung carcinoma


subject: UMLS:C2716992

object_name: precancerous condition


subject: UNII:F7BD3Z4X8L

subject_name: Pafolacianine

object_name: Metastatic Childhood Malignant Solid Neoplasm


subject: UNII:F7BD3Z4X8L

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:F7BD3Z4X8L

object_name: Childhood Malignant Thoracic Neoplasm


subject: UNII:F7BD3Z4X8L

object_name: Malignant Abdominal Neoplasm


subject: UNII:F7BD3Z4X8L

object_name: Pelvic Cancer


subject: UNII:F7BD3Z4X8L

object_name: Cancer of Neck


subject: CHEBI:3213

subject_name: Bumetanide

object_name: heart failure; with decompensation


subject: CHEBI:38940

subject_name: Sunitinib

object_name: endometrium adenocarcinoma


subject: CHEBI:38940

object_name: endometrial endometrioid adenocarcinoma


subject: CHEBI:38940

object_name: endometrial serous adenocarcinoma


subject: CHEBI:38940

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:38940

object_name: uterine carcinosarcoma


subject: CHEBI:38940

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:38940

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: UMLS:C3896807

object_name: neoplasm


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: lupus nephritis


subject: CHEBI:31859

subject_name: Modafinil

object_name: Addictive amphetamine use


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:38559

subject_name: cytochrome P450

object_name: ulcerative colitis


subject: CHEBI:38559

object_name: Crohn disease


subject: UMLS:C0010762

subject_name: Cytochrome P450


subject: UMLS:C0010762


subject: UMLS:C5554917

subject_name: Anti-FOXP3 Antisense Oligonucleotide AZD8701

object_name: triple-negative breast carcinoma


subject: UMLS:C5554917

object_name: clear cell renal carcinoma


subject: UMLS:C5554917

object_name: gastroesophageal cancer


subject: UMLS:C5554917

object_name: small cell lung carcinoma


subject: UMLS:C5554917

object_name: cervical cancer


subject: UMLS:C5554917

object_name: cervical carcinoma


subject: UMLS:C5554917

object_name: melanoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: UNII:1C6V77QF41

object_name: Deficiency of vitamin D3


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27974

subject_name: Estriol

object_name: Vulvovaginal Atrophy


subject: CHEBI:9168

subject_name: Sirolimus

object_name: skin cancer


subject: UNII:PE952ANF83

subject_name: Uproleselan

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Did not receive therapy or drug for


subject: CHEBI:28830

subject_name: Chlorambucil

object_name: acute lymphoblastic leukemia


subject: CHEBI:28830

object_name: lymphoid leukemia


subject: MESH:D013607

subject_name: Tablets


subject: MESH:D013607


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: liver cancer


subject: UMLS:C1258613

object_name: liver neoplasm


subject: UMLS:C1258613

object_name: Adult Liver Carcinoma


subject: UMLS:C1258613

object_name: liver carcinoma


subject: CHEBI:36791

subject_name: Escitalopram

object_name: chronic kidney disease


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C0351302

subject_name: sodium salts

object_name: bipolar disorder


subject: CHEBI:26714

subject_name: sodium salt


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: radius fracture


subject: CHEBI:32599


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: chronic pain (diagnosis)


subject: CHEBI:5855

object_name: Chronic pain


subject: CHEBI:9907

subject_name: ursodiol

object_name: nodular regenerative hyperplasia of the liver


subject: UMLS:C4279823

object_name: multiple sclerosis


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: diarrhea


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:144094

subject_name: bicalutamide

object_name: triple-negative breast carcinoma


subject: PR:000015283

subject_name: serine/threonine-protein kinase SMG1

object_name: Parkinson disease


subject: PR:000023092

subject_name: lipoyl synthase


subject: UniProtKB:P60716

subject_name: LIPA_ECOLI Lipoyl synthase (sprot)


subject: CHEBI:125628

subject_name: Alisertib

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:125628

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:125628

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:125628

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:125628

object_name: Non-small cell lung cancer recurrent


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Advanced cancer


subject: UMLS:C3827149


subject: UNII:A2VM2V569A

object_name: prostate carcinoma


subject: UNII:A2VM2V569A

object_name: prostate cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Emergence Delirium


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEMBL.COMPOUND:CHEMBL2109388

subject_name: FUTUXIMAB

object_name: carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109388

object_name: metastatic colorectal cancer


subject: UMLS:C4726993

subject_name: futuximab


subject: UMLS:C4726993


subject: UNII:1W7BD1M08N

subject_name: MODOTUXIMAB


subject: UNII:1W7BD1M08N


subject: UMLS:C4726629

subject_name: Modotuximab


subject: UMLS:C4726629


subject: UMLS:C3252350


subject: DRUGBANK:DB05173


subject: CHEBI:2786

subject_name: Apotransferrin

object_name: Reperfusion Injury


subject: UMLS:C0052226

subject_name: apotransferrin


subject: CHEBI:15552

subject_name: Epoprostenol


subject: CHEBI:17858

subject_name: oxiglutatione


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:16856

subject_name: Glutathione


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Encounter due to In vitro fertilization


subject: CHEBI:2668

subject_name: Amlodipine

object_name: hyperlipidemia


subject: CHEBI:2668

object_name: hyperlipoproteinemia


subject: CHEBI:2668

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:2668

object_name: Serum lipids high (finding)


subject: CHEBI:3139

subject_name: bleomycin

object_name: head and neck squamous cell carcinoma


subject: CHEBI:174615

object_name: plasma cell leukemia


subject: CHEBI:174615

object_name: plasmacytoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Plasma cell myeloma refractory


subject: CHEBI:175901

object_name: Plasma cell myeloma recurrent


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:75551

object_name: cardiovascular disorder


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor


subject: UMLS:C3854325

object_name: Myelofibrosis due to another disorder


subject: UMLS:C3854325

object_name: myelofibrosis


subject: UNII:7DT29059VX

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:7DT29059VX

object_name: Adult Soft Tissue Sarcoma


subject: UNII:7DT29059VX

object_name: sarcoma


subject: UNII:7DT29059VX

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:7DT29059VX

object_name: soft tissue sarcoma


subject: CHEBI:4910

subject_name: Etomidate

object_name: coronary artery disorder


subject: CHEBI:4910

object_name: coronary atherosclerosis


subject: UMLS:C5963600

subject_name: CDK4/6 Degrader BTX-9341

object_name: Childhood Breast Carcinoma


subject: UMLS:C5963600

object_name: breast carcinoma


subject: UMLS:C5963600

object_name: breast cancer


subject: CHEBI:45716

subject_name: Vorinostat

object_name: transitional cell carcinoma


subject: CHEBI:45716

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:45716

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:45716

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:45716

object_name: Transitional cell cancer of the renal pelvis and ureter localised


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: bladder tumor


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: urinary bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: urinary bladder cancer


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:435949

object_name: Myelodysplasia, CTCAE


subject: PUBCHEM.COMPOUND:435949

object_name: myeloid leukemia


subject: PUBCHEM.COMPOUND:435949

object_name: monocytic leukemia


subject: PUBCHEM.COMPOUND:435949

object_name: acute monocytic leukemia


subject: PUBCHEM.COMPOUND:435949

object_name: lymphoid leukemia


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Advanced Nasopharyngeal Carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: kidney disorder


subject: CHEBI:194135

subject_name: Ofloxacin

object_name: Unexplained infertility


subject: CHEBI:194135

object_name: intrauterine disorder


subject: CHEBI:194135

object_name: Abnormal uterine bleeding


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: UMLS:C4704764

object_name: neoplasm


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Voiding Disorders


subject: CHEBI:71940

object_name: outcomes general quality of life


subject: CHEBI:71940

object_name: Perceived quality of life


subject: CHEBI:71940

object_name: Good quality of life


subject: UMLS:C4708390

subject_name: Tamsulosin hydrochloride 400 microgram prolonged-release oral capsule


subject: UMLS:C4708390

object_name: lower urinary tract symptom


subject: UMLS:C4708390


subject: UMLS:C4708390


subject: UMLS:C4708390


subject: PUBCHEM.COMPOUND:9960701

subject_name: NuvaRing

object_name: Uses contraception (finding)


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: autoimmune polyendocrinopathy


subject: UNII:73B0K5S26A

object_name: antiphospholipid syndrome


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Low back pain


subject: CHEBI:180664

subject_name: Tempol

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:180664

object_name: Embolism, Tumor


subject: CHEBI:180664

object_name: Neoplasm Metastasis


subject: CHEBI:9168

subject_name: Sirolimus

object_name: IgG4-related retroperitoneal fibrosis


subject: CHEBI:499361

subject_name: Aprepitant

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:499361

object_name: obesity


subject: CHEBI:499361

object_name: Obesity, CTCAE


subject: MESH:C574900

subject_name: Pico-Salax

object_name: Hyponatremia


subject: MESH:C574900

object_name: Hyponatremia, CTCAE


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018

object_name: pancreatic neoplasm


subject: UMLS:C5237721

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5237721

object_name: malignant pancreatic neoplasm


subject: UMLS:C4763757

subject_name: Erfonrilimab


subject: UMLS:C4763757


subject: UMLS:C4763757


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Castration-Sensitive Prostate Carcinoma


subject: UMLS:C4053669


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: vascular dementia


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Myasthenia Gravis, Generalized


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:36791

subject_name: Escitalopram

object_name: generalized anxiety disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Pregnant


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:3J4JP3286H

subject_name: Fddnp F-18

object_name: Parkinsonism


subject: UNII:3J4JP3286H

object_name: multiple system atrophy


subject: UNII:3J4JP3286H

object_name: progressive supranuclear palsy


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:139350422

object_name: tumor of uterus


subject: PUBCHEM.COMPOUND:139350422

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:139350422

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:139350422

object_name: endometrial carcinoma


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UMLS:C0753357

subject_name: MultiHance

object_name: Brain Pathology


subject: DRUGBANK:DB16480

object_name: triple-negative breast carcinoma


subject: DRUGBANK:DB16480

object_name: Triple-Negative Breast Cancer Finding


subject: DRUGBANK:DB16480

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB16480

object_name: pancreatic neoplasm


subject: DRUGBANK:DB16480

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB16480

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB16480

object_name: bladder tumor


subject: DRUGBANK:DB16480

object_name: urinary bladder carcinoma


subject: DRUGBANK:DB16480

object_name: urinary bladder cancer


subject: DRUGBANK:DB16480

object_name: childhood bladder carcinoma


subject: DRUGBANK:DB16480

object_name: melanoma


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: colorectal cancer


subject: CHEBI:194095

object_name: colorectal carcinoma


subject: CHEBI:194095

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: MESH:D022401

subject_name: Meningococcal Vaccines

object_name: meningococcal infection


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: Carcinoma breast stage IV


subject: CHEBI:9123

subject_name: Sertraline

object_name: Stress


subject: CHEBI:9123

object_name: Cognitive changes


subject: CHEBI:9123

object_name: NEUROTICISM


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:83527

subject_name: Desvenlafaxine


subject: CHEBI:83527


subject: CHEBI:83527


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: periapical tissue disease


subject: UMLS:C4055175

subject_name: Curcumin-based Gel


subject: UMLS:C5708954

object_name: complete trisomy 21


subject: UMLS:C5708954

object_name: Down syndrome


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: metastatic colorectal cancer


subject: UMLS:C4527158


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Prediabetes


subject: CHEBI:32184

subject_name: Tazarotene

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:32184

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C0307785

subject_name: Tears Naturale Free

object_name: dry eye syndrome


subject: UMLS:C0307785

object_name: Dry Eye, CTCAE


subject: UMLS:C0307785

object_name: Dryness of eye


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: Recurrent depressive disorder


subject: UMLS:C5556552

subject_name: HSP90 Peptide Vaccine AST-021p

object_name: Advanced cancer


subject: CHEBI:149504

object_name: obesity


subject: CHEBI:6541

subject_name: Losartan


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: hepatitis C


subject: CHEBI:188562

subject_name: Tofimilast

object_name: COPD, severe early onset


subject: CHEBI:188562

object_name: chronic obstructive pulmonary disease


subject: CHEBI:28593

subject_name: Quinidine

object_name: Advanced chronic liver disease


subject: HMDB:HMDB0033369

subject_name: Hydroxypropyl methylcellulose

object_name: corneal ectasia


subject: HMDB:HMDB0033369

object_name: keratoconus


subject: CHEBI:30618

subject_name: hydroxypropyl methylcellulose


subject: CHEBI:30618


subject: UNII:B1QE5P712K

subject_name: hypromellose 2208 (100 MPA.S)


subject: UNII:B1QE5P712K


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Shoulder pain


subject: CHEBI:150712

object_name: stroke disorder


subject: CHEBI:150712

object_name: cerebrovascular disorder


subject: CHEBI:150712

object_name: Stroke (heart beat)


subject: CHEBI:150712

object_name: Stroke, CTCAE


subject: CHEBI:150712

object_name: Rotator Cuff Injuries


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:94714

subject_name: Doxofylline

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:94714


subject: CHEBI:94366

subject_name: itraconazole

object_name: pulmonary fibrosis


subject: CHEBI:94366

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:28918

subject_name: Epinephrine

object_name: asthma


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Nasopharyngeal cancer recurrent


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:75929

object_name: Panic attack


subject: CHEBI:75929

object_name: nicotine dependence


subject: CHEBI:75929

object_name: Nicotine Addiction


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: CHEBI:40009


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Childhood Glioblastoma


subject: UNII:52CMI0WC3Y

object_name: adult glioblastoma


subject: UNII:52CMI0WC3Y

object_name: Recurrent tumor


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:9738

subject_name: Trimipramine

object_name: glioblastoma


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:9738


subject: UNII:7A1PJO5PCK

subject_name: LSALT PEPTIDE

object_name: acute kidney failure


subject: UNII:7A1PJO5PCK

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C5943245

subject_name: LSALT Peptide


subject: UMLS:C5943245


subject: UMLS:C0723176

subject_name: SFC (Brand Name)

object_name: COVID-19 respiratory infection


subject: UMLS:C1832035

object_name: primary cutaneous lymphoma


subject: UMLS:C1832035

object_name: Cutaneous lymphoma


subject: UMLS:C1832035

object_name: hematologic disorder


subject: UMLS:C5206857

subject_name: 5-HT4 Agonist TAK-954

object_name: Enteral feeding intolerance


subject: UMLS:C5206857

object_name: Critical Illness


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Chronic viral hepatitis B without delta-agent


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: UMLS:C1572570

subject_name: PEANUT preparation

object_name: Inflammation


subject: UMLS:C2984033

object_name: plasma cell myeloma


subject: UNII:25CG88L0BB

subject_name: Brensocatib

object_name: Hepatic impairment


subject: CHEBI:601027

subject_name: Aliskiren

object_name: diabetic kidney disease


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Agitation


subject: CHEBI:8461

subject_name: Promethazine


subject: UMLS:C4727551

subject_name: Colorectal Cancer Peptide Vaccine PolyPEPI1018

object_name: colorectal cancer


subject: UMLS:C4727551

object_name: colorectal carcinoma


subject: UMLS:C4727551

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:49086

object_name: Hypoxia, in liveborn infant


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:4856

subject_name: Esmolol

object_name: Acute Stroke


subject: UMLS:C5544403

subject_name: Secretome

object_name: lupus erythematosus


subject: CHEBI:47898

subject_name: Epirubicin

object_name: esophageal adenocarcinoma


subject: CHEBI:47898

object_name: gastric adenocarcinoma


subject: UNII:7DR7JMB8BH

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:7DR7JMB8BH

object_name: Non-small cell lung cancer recurrent


subject: UNII:7DR7JMB8BH

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:7DR7JMB8BH

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:7DR7JMB8BH

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:7DR7JMB8BH

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: CHEBI:17824

subject_name: isopropanol

object_name: Nausea, CTCAE_5


subject: CHEBI:17824

object_name: Nausea


subject: CHEBI:17824

object_name: Nausea, CTCAE_3


subject: CHEBI:4910

subject_name: Etomidate

object_name: Depressed mood


subject: CHEBI:4910

object_name: Cancer patients and suicide and depression


subject: CHEBI:4910

object_name: Depressed - symptom


subject: CHEBI:4910

object_name: Depression, CTCAE


subject: CHEBI:49648

subject_name: holmium atom

object_name: Childhood Breast Carcinoma


subject: CHEBI:49648

object_name: breast carcinoma


subject: CHEBI:49648

object_name: breast cancer


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: HIV infection


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: CHEBI:71954

subject_name: Buparlisib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: cystoid macular edema


subject: CHEBI:51230

object_name: anterior uveitis


subject: CHEBI:63925

subject_name: PhXa 85


subject: CHEBI:63925


subject: CHEBI:188986

subject_name: idose


subject: CHEBI:188986


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Pruritus, CTCAE


subject: CHEBI:7773

object_name: Pruritus


subject: UMLS:C3489467

object_name: cholestasis


subject: UMLS:C3489467

object_name: primary biliary cholangitis


subject: UMLS:C3489467

object_name: sclerosing cholangitis


subject: UMLS:C3489467

object_name: primary sclerosing cholangitis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:134892

subject_name: Hexaminolevulinate

object_name: Genital lichen planus


subject: CHEBI:40279

subject_name: Allopurinol

object_name: acute kidney failure


subject: CHEBI:15365

subject_name: Aspirin

object_name: HIV-1 infection


subject: CHEBI:15365

object_name: meningeal tuberculosis


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:63607


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Acute bacterial sinusitis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Musculoskeletal Pain


subject: CHEBI:135926

subject_name: Udenafil

object_name: Hepatic impairment


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Catheter related complication


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C1619357

subject_name: Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

object_name: liver carcinoma


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: developmental and epileptic encephalopathy


subject: CHEBI:63638

object_name: West syndrome


subject: CHEBI:63638

object_name: Infantile Spasm


subject: CHEBI:8378

subject_name: Prednisolone


subject: PUBCHEM.COMPOUND:71300864


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UNII:9NKZ9LYZ06

subject_name: cenderitide

object_name: heart failure


subject: UNII:9NKZ9LYZ06

object_name: Heart Failure, CTCAE


subject: UNII:9NKZ9LYZ06

object_name: congestive heart failure


subject: UNII:9NKZ9LYZ06

object_name: ADHF


subject: CHEMBL.COMPOUND:CHEMBL2108721

subject_name: CENDERITIDE


subject: CHEMBL.COMPOUND:CHEMBL2108721


subject: CHEMBL.COMPOUND:CHEMBL2108721


subject: CHEMBL.COMPOUND:CHEMBL2108721


subject: UMLS:C3502292


subject: UMLS:C3502292


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine

object_name: Post-Operative Pain


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: UMLS:C1999829

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: neoplasm


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: colorectal cancer


subject: UNII:68AYS9A614

object_name: colorectal carcinoma


subject: UNII:68AYS9A614

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:68AYS9A614

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C0042397

subject_name: Vasoconstrictor Agents

object_name: atopic conjunctivitis


subject: UMLS:C4255305

subject_name: Vasoconstrictor [EPC]


subject: MESH:C116580

subject_name: fructooligosaccharide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C116580

object_name: obesity


subject: MESH:C116580

object_name: Obesity, CTCAE


subject: MESH:C116580

object_name: vitamin D deficiency


subject: UMLS:C5417886

object_name: esophageal squamous cell carcinoma


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: Relapse multiple myeloma


subject: UMLS:C3826989


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C0947610

subject_name: watercress preparation

object_name: Long-Term Effects Secondary to Cancer Therapy in Adults


subject: DRUGBANK:DB10664

subject_name: Watercress


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: metastatic colorectal cancer


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:230470

subject_name: rezafungin acetate

object_name: pneumocystosis


subject: UNII:W1U1TMN677

subject_name: Biafungin acetate


subject: CHEBI:229680

subject_name: Rezafungin


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:19J3781LPM

object_name: chronic leukemia


subject: UNII:19J3781LPM

object_name: plasma cell leukemia


subject: UNII:19J3781LPM

object_name: plasma cell myeloma


subject: UNII:19J3781LPM

object_name: acute leukemia


subject: CHEBI:4495

subject_name: Diazoxide

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: CHEBI:4495

object_name: digestive system neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: PUBCHEM.COMPOUND:11332179


subject: CHEBI:71940

subject_name: Tadalafil


subject: CHEBI:71940

object_name: gastric adenocarcinoma


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: glioblastoma


subject: UNII:4Z63YK6E0E

object_name: Childhood Glioblastoma


subject: UNII:4Z63YK6E0E

object_name: adult glioblastoma


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: antiphospholipid syndrome


subject: CHEMBL.COMPOUND:CHEMBL4298023

object_name: Acne inversa


subject: UNII:6K6L7E3F1L

subject_name: Gefapixant

object_name: Acute cough


subject: MESH:C000708971

subject_name: genexol-PM

object_name: Carcinoma breast stage IV


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Tachycardia by ECG Finding


subject: CHEBI:28918

object_name: Tachycardia


subject: CHEBI:28918

object_name: Bradycardia by ECG Finding


subject: CHEBI:28918

object_name: Bradycardia


subject: CHEBI:28918

object_name: hypertension


subject: CHEBI:28918

object_name: Hypertension, CTCAE


subject: CHEBI:28918

object_name: Arrhythmia


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: endogenous depression


subject: UNII:I031V2H011

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:155487963

subject_name: UK

object_name: Adenocarcinoma of colon recurrent


subject: PR:000023663

subject_name: uridylate kinase


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist

object_name: hypogonadism


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: amputation; postoperative, sequelae


subject: CHEBI:36088

subject_name: thromboxanes A

object_name: Stiff elbow


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Blast Phase


subject: CHEBI:70839

object_name: Blastic Phase


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: follicular lymphoma


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:221840

object_name: peritoneum cancer


subject: CHEBI:221840

object_name: fallopian tube carcinoma


subject: CHEBI:221840

object_name: fallopian tube cancer


subject: CHEBI:221840

object_name: ovarian cancer


subject: CHEBI:221840

object_name: ovarian neoplasm


subject: CHEBI:221840

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: atopy


subject: UNII:2P471X1Z11

object_name: pervasive developmental disorder


subject: UNII:2P471X1Z11

object_name: autism


subject: UNII:2P471X1Z11

object_name: autism spectrum disorder


subject: CHEBI:58270

subject_name: N-acetyl-L-leucinate

object_name: ataxia telangiectasia


subject: CHEBI:17786

subject_name: L-Acetylleucine


subject: UMLS:C4547971


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Induced Abortion Finding


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:61080

subject_name: Romidepsin

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:61080

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:61080

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:61080

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:61080

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:61080

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:61080

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:61080

object_name: Adult Acute Promyelocytic Leukemia


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Inflammatory Response


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:58097


subject: CHEBI:6456

subject_name: Lidocaine


subject: MESH:D022341

subject_name: Yellow Fever Vaccine

object_name: atopic eczema


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus

object_name: Infection


subject: DRUGBANK:DB19282

object_name: infectious disease


subject: DRUGBANK:DB19282

object_name: Adverse Event Associated with Infection


subject: CHEBI:184555

subject_name: Xylan Sulfate

object_name: radiation cystitis


subject: UMLS:C5417881

subject_name: Volrustomig

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1328093

subject_name: Melanoma Helper Peptide Vaccine

object_name: skin melanoma


subject: UMLS:C1328092

subject_name: Multi-epitope Melanoma Peptide Vaccine


subject: UNII:GN2UOJ9QUZ

subject_name: TETANUS TOXOID HELPER PEPTIDE


subject: UMLS:C1515333

subject_name: Tetanus Toxoid Helper Peptide


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Alzheimer disease type 1


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: Alzheimer disease


subject: CHEBI:138655


subject: CHEBI:138655

object_name: colon carcinoma


subject: CHEBI:138655

object_name: colorectal cancer


subject: CHEBI:138655

object_name: colon cancer


subject: CHEBI:138655

object_name: Stomach cancer


subject: CHEBI:138655

object_name: gastric cancer


subject: CHEBI:138655

object_name: Microsatellite instability-high solid malignant tumor


subject: PR:000015485

subject_name: spermatogenesis-associated protein 2


subject: PR:000015485


subject: PR:000015485


subject: PR:000015485


subject: PR:000015485


subject: PR:000015485


subject: PR:000015485


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: breast cancer


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UMLS:C2987605


subject: UMLS:C2987605


subject: UMLS:C1831888


subject: UMLS:C1831888


subject: UMLS:C1831888


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Retinal neovascularization


subject: UNII:15C2VL427D

object_name: cystoid macular edema


subject: UNII:15C2VL427D

object_name: Pathologic Neovascularization


subject: UNII:15C2VL427D

object_name: Recurrent pterygium


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: graft versus host disease


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: UNII:FU88PI0433

subject_name: ARZOXIFENE HYDROCHLORIDE

object_name: ovarian cancer


subject: UNII:FU88PI0433

object_name: ovarian neoplasm


subject: UNII:FU88PI0433

object_name: ovarian carcinoma


subject: UNII:FU88PI0433

object_name: peritoneum cancer


subject: UMLS:C1527089

subject_name: Arzoxifene Hydrochloride


subject: UMLS:C1527089


subject: UMLS:C1527089


subject: UMLS:C1527089


subject: UMLS:C2744646

object_name: pancreatic adenocarcinoma


subject: UMLS:C2744646

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C2744646

object_name: Metastatic Lesion


subject: UMLS:C2744646

object_name: malignant endocrine neoplasm


subject: UMLS:C2744646

object_name: Carcinoma of Endocrine Gland


subject: UMLS:C2744646

object_name: neoplasm


subject: UMLS:C2744646

object_name: cancer


subject: UMLS:C0677669

object_name: liver cancer


subject: UMLS:C0677669

object_name: liver neoplasm


subject: UMLS:C0677669

object_name: Adult Liver Carcinoma


subject: UMLS:C0677669

object_name: liver carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: beta thalassemia


subject: CHEBI:9168

object_name: beta-thalassemia HBB/LCRB


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: Prostate cancer recurrent


subject: CHEBI:95021

subject_name: pemetrexed

object_name: fallopian tube cancer


subject: CHEBI:95021


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: AIDS


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: concussion


subject: UMLS:C0002521

object_name: Mild Traumatic Brain Injury


subject: CHEBI:8024

subject_name: Perindopril

object_name: Dyslipidemia


subject: CHEBI:15414

subject_name: Adomet

object_name: endogenous depression


subject: CHEBI:15414

object_name: major depressive disorder


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:67040


subject: CHEBI:149509

object_name: Heart Failure, CTCAE


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:91435

subject_name: Linifanib

object_name: Solid Neoplasm


subject: UMLS:C1738762

subject_name: ABT 869


subject: PUBCHEM.COMPOUND:49800030

subject_name: METHYLPREDNISOLONE ACETATE

object_name: arthrosis; post-traumatic


subject: PUBCHEM.COMPOUND:49800030

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: PUBCHEM.COMPOUND:584547


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: UMLS:C4507515

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:31355

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:31355

object_name: ovarian sarcoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:79699

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699

object_name: Endometrial cancer stage III


subject: CHEBI:79699

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:79699

object_name: malignant epithelial tumor of ovary


subject: CHEBI:79699


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:231679

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:231679

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:231679

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:231679

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:231679

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:231679

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:231679

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:TBF1NHY02O

subject_name: AMCENESTRANT

object_name: Decreased liver function


subject: UMLS:C4687517


subject: UMLS:C5421014

subject_name: Amcenestrant


subject: UNII:64FS3BFH5W

subject_name: EPOETIN

object_name: asphyxia


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: UMLS:C0014822

subject_name: Erythropoietin


subject: CHEBI:231369

subject_name: Savolitinib

object_name: lung sarcomatoid carcinoma


subject: UNII:7DR7JMB8BH


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: CHEBI:66899

subject_name: Tafluprost

object_name: glaucoma


subject: CHEBI:66899

object_name: Glaucoma, CTCAE


subject: CHEBI:4702

subject_name: Dorzolamide

object_name: Ocular surface disease


subject: CHEBI:4702

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:60787

subject_name: TIMOLOL


subject: CHEBI:60787


subject: UNII:6MUO20693U

object_name: Solid Neoplasm


subject: UMLS:C4722474

subject_name: ISO-Fludelone


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: Xerostomia


subject: CHEBI:27812

object_name: Neck Carcinoma


subject: CHEBI:27812

object_name: head and neck neoplasm


subject: CHEBI:27812

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID

object_name: Alzheimer Disease, Late Onset


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C5240006

subject_name: Vaccine product containing only acellular Bordetella pertussis antigen (medicinal product)


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: rheumatoid arthritis


subject: MESH:C079198

subject_name: S 1 (combination)


subject: UMLS:C5667059

object_name: glioblastoma


subject: UMLS:C5667059

object_name: Childhood Glioblastoma


subject: UMLS:C5667059

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:147740

subject_name: Yasmin

object_name: Uses contraception (finding)


subject: UMLS:C0939533


subject: UMLS:C0306371

subject_name: Humulin R

object_name: Burn injury


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: Alopecia of scalp


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Indolent lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:7465

subject_name: Naltrexone

object_name: osteoarthritis


subject: CHEBI:7465

object_name: psoriatic arthritis


subject: CHEBI:7465


subject: CHEBI:8884

subject_name: Rocuronium

object_name: acute respiratory distress syndrome


subject: CHEBI:8884

object_name: Mechanical ventilation finding


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: Infection


subject: CHEBI:63717

object_name: infectious disease


subject: CHEBI:63717

object_name: Adverse Event Associated with Infection


subject: CHEBI:82960

subject_name: Raltegravir


subject: CHEBI:82960


subject: CHEBI:82960


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: small intestine adenocarcinoma


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: tuberous sclerosis


subject: CHEBI:63638

object_name: situs inversus


subject: CHEBI:63638

object_name: tuberous sclerosis 1


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Hypercholesterolemia


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351

object_name: coronary atherosclerosis


subject: CHEBI:87631

subject_name: statin

object_name: cardiogenic shock


subject: CHEBI:87631

object_name: recurrent myocardial infarction


subject: CHEBI:87631

object_name: acute coronary syndrome


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:94366

subject_name: itraconazole

object_name: Alzheimer disease type 1


subject: UMLS:C5774060

subject_name: Prurisol

object_name: psoriasis


subject: CHEBI:149509

object_name: Post-Traumatic Headache


subject: CHEBI:149509

object_name: traumatic encephalopathy


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Burn injury


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: hypertension


subject: UNII:71M78END5S

object_name: Hypertension, CTCAE


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEBI:49140

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:49140

object_name: colorectal neoplasm


subject: UMLS:C0092882


subject: UMLS:C0092882


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: acute cholecystitis


subject: PUBCHEM.COMPOUND:3367

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C3641791

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C3641791

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PR:000001379


subject: UNII:BTY153760O

subject_name: Ixekizumab


subject: CHEBI:231683

subject_name: Anakinra

object_name: hyperinsulinism


subject: CHEBI:231683

object_name: Hyperinsulinemia


subject: CHEBI:231683

object_name: Prediabetes


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: UMLS:C4045705

object_name: Neck Carcinoma


subject: UMLS:C4045705

object_name: head and neck neoplasm


subject: UMLS:C4045705

object_name: head and neck cancer


subject: CHEBI:45783

subject_name: Imatinib

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:45783

object_name: Stage IVB adult soft tissue sarcoma


subject: CHEBI:45783

object_name: Drug toxicity


subject: CHEBI:45783

object_name: Drug usage


subject: CHEBI:45783

object_name: Drug use history


subject: CHEBI:45783

object_name: Encounter due to drug use


subject: CHEBI:229764

subject_name: Selinexor

object_name: Plexosarcoma


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:53218

object_name: asthma


subject: CHEBI:7936

subject_name: Paroxetine

object_name: coronary microvascular disorder


subject: CHEBI:7936

object_name: Heart Disease Risk Factors


subject: CHEBI:7936

object_name: Postmenopausal flushing


subject: CHEBI:6121

subject_name: Ketamine

object_name: peripheral nervous system disorder


subject: CHEBI:6121

object_name: neuropathy


subject: CHEBI:6121

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6121

object_name: neurotoxicity


subject: KEGG.COMPOUND:C02380

object_name: childhood acute lymphoblastic leukemia


subject: KEGG.COMPOUND:C02380

object_name: adult acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib


subject: PUBCHEM.COMPOUND:73005958


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:141441

subject_name: Ile-Thr


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: CHEBI:59204

subject_name: Carbetocin

object_name: adverse effect of oxytocic drugs


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: DRUGBANK:DB17491

object_name: digestive system cancer


subject: DRUGBANK:DB17491

object_name: gastric adenocarcinoma


subject: DRUGBANK:DB17491

object_name: colorectal adenocarcinoma


subject: DRUGBANK:DB17491

object_name: pancreatic adenocarcinoma


subject: DRUGBANK:DB17491

object_name: liver carcinoma


subject: DRUGBANK:DB17491

object_name: carcinoma of esophagus


subject: DRUGBANK:DB17491

object_name: bile duct carcinoma


subject: UMLS:C3275040

object_name: stroke disorder


subject: UMLS:C3275040

object_name: cerebrovascular disorder


subject: UMLS:C3275040

object_name: Stroke (heart beat)


subject: UMLS:C3275040

object_name: Stroke, CTCAE


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: primary central nervous system lymphoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: non-Hodgkin lymphoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: lymphoma


subject: UNII:D07V79Q44T


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Ovulation disorder


subject: CHEBI:7953

subject_name: Pemoline

object_name: cocaine abuse


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: vulvar squamous cell carcinoma


subject: UNII:DPT0O3T46P

object_name: anal squamous cell carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Complication of transplanted liver


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:520985

subject_name: Almotriptan

object_name: migraine without aura, susceptibility to, 4


subject: CHEBI:520985

object_name: Common Migraine


subject: CHEBI:520985

object_name: migraine with aura


subject: UMLS:C0746901

subject_name: NIFEDIPINE XL

object_name: severe pre-eclampsia


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: Adverse event following immunization


subject: MESH:C000722934

subject_name: CVnCoV COVID-19 vaccine


subject: CHEBI:50858

subject_name: corticosteroid

object_name: temporal arteritis


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C5666976

subject_name: Oncolytic Virus RT-01

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: lung large cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Non-small cell lung cancer stage II


subject: UNII:2S9ZZM9Q9V

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:2S9ZZM9Q9V

object_name: minimally invasive lung adenocarcinoma


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: prolactin producing pituitary tumor


subject: PUBCHEM.COMPOUND:56998

object_name: tuberculosis


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: UNII:A38FQW405V


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: multiple sclerosis


subject: CHEBI:23965

subject_name: estradiol

object_name: urinary tract infection


subject: CHEBI:23965

object_name: Recurrent cystitis


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Tourette syndrome


subject: CHEBI:176724

object_name: tic disorder


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:50692

subject_name: Mifepristone

object_name: bipolar disorder


subject: UMLS:C0728761

subject_name: Velban

object_name: adult lymphoma


subject: UMLS:C0728761

object_name: lymphoma


subject: UMLS:C0728761

object_name: pediatric lymphoma


subject: UNII:VWJ4VVZ3OU

object_name: Blood Clot


subject: UNII:VWJ4VVZ3OU

object_name: thrombosis


subject: UNII:VWJ4VVZ3OU

object_name: Thrombosis of blood vessel


subject: MESH:C000627108

object_name: asthma


subject: UMLS:C4705670


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: systemic sclerosis


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Reperfusion Injury


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEMBL.COMPOUND:CHEMBL3545222

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEMBL.COMPOUND:CHEMBL3545222

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL3545222

object_name: chronic obstructive pulmonary disease


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: bladder tumor


subject: CHEBI:77562

object_name: urethra neoplasm


subject: CHEBI:77562

object_name: ureter cancer


subject: CHEBI:77562

object_name: ureter neoplasm


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab


subject: UNII:38RL9AE51Q

object_name: scleroderma


subject: CHEBI:18248

subject_name: Iron

object_name: autosomal dominant hypophosphatemic rickets


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C2987346

subject_name: SurVaxM

object_name: glioblastoma


subject: UMLS:C2987346

object_name: Childhood Glioblastoma


subject: UMLS:C2987346

object_name: adult glioblastoma


subject: CHEBI:75722

subject_name: Tramadol

object_name: fibromyalgia


subject: CHEBI:6801

subject_name: Metformin

object_name: AIDS


subject: PUBCHEM.COMPOUND:71711862

object_name: neuralgia


subject: PUBCHEM.COMPOUND:71711862

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:71711862

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:71711862

object_name: Diabetes


subject: PUBCHEM.COMPOUND:71711862

object_name: diabetes mellitus


subject: UNII:889I657R9P

subject_name: Desmethylsibutramine

object_name: cardiovascular disorder


subject: UNII:889I657R9P

object_name: heart disorder


subject: UNII:987R943R3P

subject_name: Didesmethylsibutramine


subject: UNII:987R943R3P


subject: CHEBI:9137

subject_name: Sibutramine


subject: CHEBI:9137


subject: CHEMBL.COMPOUND:CHEMBL2108210

subject_name: LAVENDER OIL

object_name: neonatal abstinence syndrome


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Effects of immunosuppressant therapy


subject: CHEBI:9168

object_name: Acute rejection of liver transplant


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Kinetic tremor


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:28837

subject_name: Caprylic acid


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Anemia in malignant neoplastic disease


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:63607

subject_name: Linezolid

object_name: Sepsis


subject: CHEBI:63607

object_name: Sepsis, CTCAE


subject: UMLS:C1703313

subject_name: Papacarie

object_name: outcomes general quality of life


subject: UMLS:C1703313

object_name: Perceived quality of life


subject: UMLS:C1703313

object_name: Good quality of life


subject: UMLS:C1703313

object_name: dental caries


subject: UMLS:C1703313

object_name: Dental Caries, CTCAE


subject: MESH:C000611388

subject_name: moluodan

object_name: Gastric Precancerous Condition


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: acute graft versus host disease


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Anaemias due to disorders of glutathione metabolism


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: pyelonephritis


subject: PUBCHEM.COMPOUND:22982613

object_name: non-small cell lung carcinoma


subject: MESH:D002021

subject_name: Buffers

object_name: diarrhea


subject: MESH:D002021

object_name: rectal discharge diarrhea (physical finding)


subject: MESH:D002021

object_name: Diarrhea, CTCAE


subject: MESH:C117173

subject_name: THC 5

object_name: cannabis abuse


subject: MESH:C117173

object_name: Traffic accidents


subject: MESH:C000656706

object_name: osteoarthritis


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Cervix carcinoma recurrent


subject: UNII:PVI5M0M1GW

object_name: cervical squamous cell carcinoma


subject: UNII:PVI5M0M1GW

object_name: stage III cervical cancer


subject: UNII:PVI5M0M1GW

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Cervical carcinoma stage IVA


subject: UNII:PVI5M0M1GW

object_name: Cervical carcinoma stage IVB


subject: UNII:PVI5M0M1GW

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: cervical small cell carcinoma


subject: UNII:PVI5M0M1GW

object_name: cervical adenosquamous carcinoma


subject: UNII:PVI5M0M1GW

object_name: cervical adenocarcinoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Osteoarthritis of glenohumeral joint


subject: CHEBI:7009

subject_name: Moxonidine

object_name: diabetic kidney disease


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: Anastomotic stenosis


subject: CHEBI:194095

object_name: Esophageal stricture


subject: CHEBI:194095

object_name: Esophageal stenosis


subject: CHEBI:194095

object_name: Esophageal Stenosis, CTCAE


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: UMLS:C4549048

subject_name: zenocutuzumab

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C4549048

object_name: NRG1 Gene Fusion Positive


subject: UMLS:C4549048

object_name: Unknown Primary Tumors


subject: UMLS:C4549048

object_name: Neck Carcinoma


subject: UMLS:C4549048

object_name: head and neck neoplasm


subject: UMLS:C4549048

object_name: head and neck cancer


subject: UMLS:C4549048

object_name: non-small cell lung carcinoma


subject: UMLS:C4549048

object_name: pancreatic neoplasm


subject: UMLS:C4549048

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4549048

object_name: malignant pancreatic neoplasm


subject: UMLS:C4549048

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4549048

object_name: clear cell renal carcinoma


subject: UMLS:C4549048

object_name: renal cell adenocarcinoma


subject: UMLS:C4549048

object_name: renal cell carcinoma


subject: UMLS:C4549048

object_name: colorectal cancer


subject: UMLS:C4549048

object_name: colorectal carcinoma


subject: UMLS:C4549048

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4549048

object_name: cholangiocarcinoma


subject: UMLS:C4549048

object_name: prostate carcinoma


subject: UMLS:C4549048

object_name: prostate cancer


subject: UMLS:C4549048

object_name: Childhood Breast Carcinoma


subject: UMLS:C4549048

object_name: breast carcinoma


subject: UMLS:C4549048

object_name: breast cancer


subject: PUBCHEM.COMPOUND:124091099


subject: PUBCHEM.COMPOUND:124091099


subject: PUBCHEM.COMPOUND:124091099


subject: PUBCHEM.COMPOUND:124091099

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:124091099

object_name: Estrogen receptor positive tumor


subject: PUBCHEM.COMPOUND:124091099

object_name: Malignant neoplasm of female breast


subject: PUBCHEM.COMPOUND:124091099

object_name: Estrogen Receptor Positive


subject: PUBCHEM.COMPOUND:124091099

object_name: breast adenocarcinoma


subject: UNII:62GM7VW6AO


subject: UNII:62GM7VW6AO


subject: UNII:62GM7VW6AO


subject: UNII:62GM7VW6AO


subject: UNII:62GM7VW6AO


subject: UNII:62GM7VW6AO


subject: UNII:62GM7VW6AO


subject: UNII:62GM7VW6AO


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Atypical behavior


subject: CHEBI:8707

object_name: Alzheimer disease


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: beta thalassemia


subject: UMLS:C3714803

object_name: beta-thalassemia HBB/LCRB


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:4910

subject_name: Etomidate

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Melatonin deficiency


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:6K6L7E3F1L

subject_name: Gefapixant

object_name: obstructive sleep apnea syndrome


subject: UMLS:C5222458

subject_name: Ketamine Hydrochloride Injection

object_name: chronic pain (diagnosis)


subject: UMLS:C5222458

object_name: Chronic pain


subject: CHEBI:28427

subject_name: arabinoxylan

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:28427

object_name: metabolic syndrome X


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Dyslipidemia


subject: CHEBI:50733

object_name: hypertension


subject: CHEBI:50733

object_name: Hypertension, CTCAE


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Locally Advanced Hepatocellular Carcinoma


subject: CHEBI:134738

subject_name: Laquinimod

object_name: lupus nephritis


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: osteoradionecrosis


subject: CHEBI:18145


subject: CHEBI:27013

subject_name: Tocopherol


subject: UMLS:C5555533

subject_name: Anti-CDH-6 ADC DS-6000a

object_name: lung cancer


subject: UMLS:C5555533

object_name: lung neoplasm


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: pulmonary hypertension


subject: CHEBI:17061

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:17061

object_name: thalassemia


subject: CHEBI:30011

subject_name: L-glutamine residue


subject: CHEBI:30011


subject: CHEBI:30011


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:15640

subject_name: Leucovorin

object_name: peritoneum cancer


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: functional gastric disease


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Consent Type - Hysterectomy


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: Childhood Breast Carcinoma


subject: CHEBI:15698

object_name: breast carcinoma


subject: CHEBI:15698

object_name: breast cancer


subject: CHEBI:15698

object_name: breast neoplasm


subject: CHEBI:15698

object_name: adenocarcinoma


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: periodontitis


subject: UMLS:C5690696

subject_name: MitoQ

object_name: Heart failure with normal ejection fraction


subject: UMLS:C5690696

object_name: Chronic uremia


subject: CHEBI:7986


subject: CHEBI:9907

subject_name: ursodiol


subject: PUBCHEM.COMPOUND:135565610

subject_name: hetrombopag

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:135565610

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:135565610

object_name: Delayed platelet engraftment


subject: UNII:9WGT51BDDL

subject_name: Hetrombopag


subject: UNII:9WGT51BDDL


subject: UNII:9WGT51BDDL


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:4672

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UNII:19ZTZ9YC4O

object_name: ulcerative colitis


subject: UNII:19ZTZ9YC4O

object_name: inflammatory bowel disease 1


subject: UMLS:C1883555

subject_name: Whey Protein Isolate

object_name: Prediabetes


subject: CHEBI:60802

subject_name: ropivacaine

object_name: post operative nausea and vomiting


subject: GTOPDB:12347

subject_name: penpulimab

object_name: diffuse large B-cell lymphoma


subject: GTOPDB:12347

object_name: Neoplasms by Histologic Type


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:80332

subject_name: C-peptide

object_name: type 1 diabetes mellitus


subject: CHEBI:80332

object_name: hypoglycemia


subject: CHEBI:80332

object_name: Blood glucose below reference range (finding)


subject: CHEBI:80332

object_name: Hypoglycemia, CTCAE


subject: UMLS:C0006558

subject_name: C-Peptide


subject: UMLS:C0006558


subject: UMLS:C0006558


subject: UMLS:C0006558


subject: RXCUI:2122515

subject_name: dolutegravir / lamivudine Oral Product

object_name: opiate dependence


subject: UNII:5X5HB3VZ3Z

subject_name: Apricoxib

object_name: lung cancer


subject: UNII:5X5HB3VZ3Z

object_name: lung neoplasm


subject: UNII:5X5HB3VZ3Z

object_name: lung carcinoma


subject: UNII:5X5HB3VZ3Z

object_name: non-small cell lung carcinoma


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: hairy cell leukemia


subject: CHEBI:167672

object_name: refractory hairy cell leukemia


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: prolymphocytic leukemia


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415


subject: CHEBI:133021

subject_name: Venetoclax


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Hormone-dependent prostate cancer


subject: CHEBI:49845

subject_name: (R)-quinacrine

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:49845

object_name: clear cell renal carcinoma


subject: CHEBI:49845

object_name: renal cell adenocarcinoma


subject: CHEBI:49845

object_name: renal cell carcinoma


subject: CHEBI:8711

subject_name: Quinacrine


subject: CHEBI:8711


subject: CHEBI:8711


subject: CHEBI:8711


subject: CHEBI:2469

subject_name: Adefovir

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:233453


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:17549

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:17549

object_name: sarcoma


subject: CHEBI:17549

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:17549

object_name: soft tissue sarcoma


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: female reproductive system disorder


subject: CHEBI:187893

subject_name: Baclofen


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:6128

subject_name: Ketoprofen


subject: CHEBI:6532

subject_name: Loperamide


subject: UMLS:C4045746

object_name: Diabetic peripheral neuropathy


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: generalized anxiety disorder


subject: GTOPDB:8926

subject_name: glembatumumab vedotin

object_name: Recurrent Uveal Melanoma


subject: GTOPDB:8926

object_name: Stage IV Uveal Melanoma AJCC v7


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UMLS:C2698156


subject: UMLS:C2698156


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: neuralgia


subject: CHEBI:9667

object_name: Prolapsed cervical intervertebral disc


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Malignant Paraganglioma


subject: CHEBI:85994

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:149504

object_name: Hypoxemia


subject: CHEBI:149504

object_name: Hypoxia, CTCAE


subject: CHEBI:149504

object_name: sleep apnea


subject: CHEBI:149504

object_name: Chemoreceptor apnea


subject: CHEBI:149504

object_name: respiration; sleep disorder


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: CHEBI:91327

object_name: Stage II Renal Pelvis Cancer AJCC v8


subject: UMLS:C3494500

object_name: pyropoikilocytosis, hereditary


subject: UMLS:C3494500

object_name: hypophosphatasia


subject: UNII:M0Q7802G2B

subject_name: Benzodiazepines

object_name: pregnancy related


subject: UNII:M0Q7802G2B

object_name: Benzodiazepines causing adverse effects in therapeutic use


subject: UNII:M0Q7802G2B

object_name: Fetal anomaly


subject: UMLS:C4048284

subject_name: Benzodiazepine


subject: UMLS:C4048284


subject: UMLS:C4048284


subject: UMLS:C3536850

subject_name: Benzodiazepine [EPC]


subject: UMLS:C3536850


subject: UMLS:C3536850


subject: MESH:D022261

subject_name: Respiratory Syncytial Virus Vaccines

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C5907975

subject_name: Anti-CD19/Anti-CD3/Anti-CD2 Trispecific Antibody PIT565

object_name: EXCESS LMW-DNA


subject: CHEBI:91899

object_name: proctitis


subject: CHEBI:91899

object_name: Proctitis, CTCAE


subject: CHEBI:91899

object_name: proctosigmoiditis


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:3207


subject: UNII:OP35X9610Y

object_name: hormone deficiency


subject: UNII:OP35X9610Y

object_name: Congenital IGHD


subject: UNII:OP35X9610Y

object_name: Reduced circulating growth hormone concentration


subject: UNII:OP35X9610Y

object_name: endocrine system disorder


subject: PUBCHEM.COMPOUND:46874763

object_name: streptococcal pneumonia


subject: PUBCHEM.COMPOUND:46874763

object_name: Community-Acquired Infections


subject: PUBCHEM.COMPOUND:46874763

object_name: gram-positive bacterial infections


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: PUBCHEM.COMPOUND:99937

subject_name: isosorbide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:99937

object_name: obesity


subject: PUBCHEM.COMPOUND:99937

object_name: Obesity, CTCAE


subject: CHEBI:6062

subject_name: Isosorbide mononitrate


subject: CHEBI:6062


subject: CHEBI:6062


subject: CHEBI:192614

subject_name: Homosildenafil


subject: CHEBI:192614


subject: CHEBI:192614


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:8382

subject_name: Prednisone

object_name: Alzheimer disease type 1


subject: CHEBI:8382

object_name: Alzheimer disease


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:18248

subject_name: Iron

object_name: Intraoperative Hemorrhage


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:6456

subject_name: Lidocaine

object_name: atrial fibrillation


subject: CHEBI:6456

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:6456

object_name: Atrial Fibrillation, CTCAE


subject: MESH:C089950

subject_name: MF59 oil emulsion

object_name: avian influenza


subject: UMLS:C1327897

subject_name: Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine

object_name: non-Hodgkin lymphoma


subject: CHEBI:5558

subject_name: Guanfacine

object_name: Depressed mood


subject: CHEBI:5558

object_name: Cancer patients and suicide and depression


subject: CHEBI:5558

object_name: Depressed - symptom


subject: CHEBI:5558

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin


subject: PUBCHEM.COMPOUND:46783403

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C3884847

subject_name: ma zi ren wan

object_name: functional gastric disease


subject: CHEBI:95021

subject_name: pemetrexed

object_name: endometrial cancer


subject: CHEBI:95021

object_name: uterine corpus cancer


subject: CHEBI:95021

object_name: endometrial carcinoma


subject: CHEBI:95021

object_name: endometrium neoplasm


subject: CHEBI:95021

object_name: female reproductive system neoplasm


subject: CHEBI:95021

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Failed mechanical induction


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: Closed Fracture


subject: UMLS:C2346514

object_name: Physical trauma


subject: UMLS:C2346514

object_name: Injury


subject: UMLS:C2346514

object_name: Trauma


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: interstitial lung disease


subject: UMLS:C0357915

subject_name: urea cream

object_name: hand-foot syndrome


subject: UMLS:C0357915

object_name: Sickle Cell Dactylitis


subject: UMLS:C3502775

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: retinal vein occlusion


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Surgical procedure finding


subject: PUBCHEM.COMPOUND:9848990

object_name: Acute Pain


subject: CHEBI:7459

subject_name: Naloxone


subject: UMLS:C0732282

subject_name: Aggrenox

object_name: kidney failure


subject: UMLS:C0544420

subject_name: Digestive Enzymes

object_name: morbid obesity


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650

object_name: Hypoxemia


subject: CHEBI:17650

object_name: Hypoxia, CTCAE


subject: DRUGBANK:DB17669

object_name: propionic acidemia


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:31932

subject_name: olmesartan


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: IgA Nephropathy


subject: PR:000017019

object_name: Chronic uremia


subject: PR:000017019

object_name: IgA vasculitis


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:94366

subject_name: itraconazole

object_name: neoplasm


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]

object_name: osteoarthritis, knee


subject: UNII:2Q1GS25JWN

subject_name: AVOTERMIN

object_name: varicose veins


subject: UMLS:C3179443

subject_name: avotermin


subject: CHEBI:6015

subject_name: Isoflurane

object_name: cardiovascular disorder


subject: CHEBI:6015

object_name: coronary artery disorder


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:4445

subject_name: Desflurane


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Constipation


subject: CHEBI:75832

object_name: Constipation, CTCAE


subject: CHEBI:75832

object_name: Heartburn


subject: CHEBI:75832

object_name: Abdominal pain


subject: CHEBI:75832

object_name: Abdominal Pain, CTCAE


subject: CHEBI:75832

object_name: diarrhea


subject: CHEBI:75832

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:75832

object_name: Diarrhea, CTCAE


subject: CHEBI:75832

object_name: Adverse effects


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: AODR depressive state


subject: CHEBI:6950

object_name: substance withdrawal syndrome


subject: CHEBI:6950

object_name: Drug withdrawal syndrome


subject: CHEBI:6950

object_name: Drug-induced depressive state


subject: CHEBI:6950

object_name: AOD craving


subject: CHEBI:6950

object_name: substance abuse


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: bone chondrosarcoma


subject: UMLS:C4086713

object_name: chondrosarcoma


subject: UMLS:C2347130

subject_name: Millet Seed

object_name: Prediabetes


subject: CHEBI:2636

subject_name: Amifostine

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:2636

object_name: acute myeloid leukemia


subject: UMLS:C1873351

object_name: schizophrenia


subject: CHEBI:134709

subject_name: Pitolisant


subject: CHEBI:41139

subject_name: BETAINE

object_name: Insulin Sensitivity


subject: CHEBI:125427

object_name: psoriasis


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: adult lymphoma


subject: CHEBI:46195

object_name: lymphoma


subject: CHEBI:46195

object_name: pediatric lymphoma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C0768182

subject_name: Bexxar


subject: UMLS:C0768182


subject: UMLS:C0768182


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:8346

subject_name: Potassium Iodide


subject: CHEBI:8346


subject: CHEBI:8346


subject: CHEBI:74559

subject_name: Lys-Ile


subject: CHEBI:74559


subject: CHEBI:74559


subject: UMLS:C2603401

subject_name: Ki


subject: UMLS:C2603401


subject: UMLS:C2603401


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: graft versus host disease


subject: MESH:C000718187

object_name: type 2 diabetes mellitus


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Android obesity


subject: CHEBI:601027

object_name: Abdominal obesity


subject: PUBCHEM.COMPOUND:20473337

subject_name: Diethylcarbamazine

object_name: HIV infection


subject: PUBCHEM.COMPOUND:2877953

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:2877953

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:2877953

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:2877953

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C2699571

subject_name: sotatercept


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: UMLS:C5203469

subject_name: Cetuximab Liquid Injection

object_name: colorectal cancer


subject: UMLS:C1508863

subject_name: Injection, cetuximab, 10 mg administered


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: kidney failure


subject: DRUGBANK:DB14239

subject_name: Echinacea purpurea


subject: UMLS:C4287710

subject_name: Fluorescent Antibody SGM-101

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C4287710

object_name: brain cancer


subject: UMLS:C4287710

object_name: brain neoplasm


subject: UMLS:C4287710

object_name: rectal neoplasm


subject: UMLS:C4287710

object_name: brain disorder


subject: UMLS:C4287710

object_name: digestive system neoplasm


subject: UMLS:C4287710

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C4287710

object_name: digestive system disorder


subject: UMLS:C4287710

object_name: gastrointestinal disease


subject: UMLS:C4287710

object_name: digestive system cancer


subject: UMLS:C4287710

object_name: intestinal cancer


subject: UMLS:C4287710

object_name: intestinal neoplasm


subject: UMLS:C4287710

object_name: intestinal disorder


subject: UNII:7SE5582Q2P

subject_name: Vosoritide

object_name: isolated short stature


subject: UNII:7SE5582Q2P

object_name: Idiopathic short stature


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Solid Neoplasm


subject: CHEBI:142431

subject_name: Praliciguat

object_name: Heart failure with normal ejection fraction


subject: UMLS:C5198199


subject: UMLS:C0602413

object_name: pneumococcal infection


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine


subject: UMLS:C3827119

subject_name: Recombinant Human Adenovirus Type 5 H101

object_name: liver carcinoma


subject: CHEBI:3612

subject_name: chlordiazepoxide hydrochloride

object_name: Disorders associated with peritoneal dialysis


subject: CHEBI:3612

object_name: chronic kidney disease


subject: CHEBI:3612

object_name: Chronic uremia


subject: CHEBI:141213

subject_name: Isoxaflutole


subject: CHEBI:141213


subject: CHEBI:141213


subject: UMLS:C4319618

subject_name: Balance (substance)


subject: UMLS:C4319618


subject: UMLS:C4319618


subject: CHEBI:142708

object_name: Infection


subject: CHEBI:142708

object_name: infectious disease


subject: CHEBI:142708

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: CHEBI:149836


subject: MESH:C000632500

subject_name: reolysin

object_name: prostate carcinoma


subject: MESH:C000632500

object_name: prostate cancer


subject: UNII:0TJ631J0KP

object_name: asthma


subject: UMLS:C4053604

subject_name: Phosphaplatin PT-112

object_name: plasma cell myeloma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: adrenal cortex carcinoma


subject: CHEBI:85994

object_name: adenoid cystic carcinoma


subject: CHEBI:85994

object_name: salivary gland carcinoma


subject: CHEBI:85994

object_name: salivary gland cancer


subject: UMLS:C0147728

object_name: retinitis pigmentosa


subject: UMLS:C0147728

object_name: retinitis pigmentosa 1


subject: UNII:2261HH611H

subject_name: Tenalisib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:192617

subject_name: Abametapir

object_name: Pediculosis


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: allergic bronchopulmonary aspergillosis


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: UNII:2X1K91UT6N

object_name: stage II adult soft tissue sarcoma


subject: UNII:2X1K91UT6N

object_name: Stage IV adult soft tissue sarcoma


subject: UNII:2X1K91UT6N

object_name: Stage IIC Adult Soft Tissue Sarcoma


subject: UNII:2X1K91UT6N

object_name: stage III adult soft tissue sarcoma


subject: UMLS:C4282166

object_name: bladder tumor


subject: UMLS:C4282166

object_name: urinary bladder carcinoma


subject: UMLS:C4282166

object_name: urinary bladder cancer


subject: UMLS:C4282166

object_name: childhood bladder carcinoma


subject: UMLS:C4282166

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: rheumatoid arthritis


subject: PR:000004274

subject_name: ADP-ribosylation factor-like protein 10

object_name: ulcerative colitis


subject: PR:000004274

object_name: inflammatory bowel disease 1


subject: UMLS:C4727690

object_name: kidney failure


subject: UMLS:C2987384

subject_name: BMN 673

object_name: primary peritoneal carcinoma


subject: UMLS:C2987384

object_name: Primary Peritoneal Cancer


subject: UMLS:C2987384

object_name: Advanced breast cancer


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: PUBCHEM.COMPOUND:60654

subject_name: Dolasetron

object_name: fibromyalgia


subject: CHEBI:94561


subject: UNII:82WI2L7Q6E

subject_name: DOLASETRON


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Acute Rejection


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Mental deterioration


subject: CHEBI:4806

object_name: Cognitive impairment


subject: CHEBI:4806

object_name: Alzheimer disease type 1


subject: CHEBI:4806

object_name: Alzheimer disease


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: prolymphocytic leukemia


subject: CHEBI:91397

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:229764


subject: CHEBI:229764

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:229764

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:229764


subject: CHEBI:173763

subject_name: Thermophillin

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: PUBCHEM.COMPOUND:2269

object_name: interstitial lung disease 1


subject: PUBCHEM.COMPOUND:2269

object_name: interstitial lung disease 2


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: hepatobiliary disorder


subject: CHEBI:85083

object_name: liver disorder


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir


subject: PUBCHEM.COMPOUND:77335690


subject: PUBCHEM.COMPOUND:77335690

object_name: HCV coinfection


subject: UMLS:C2003486

subject_name: CMX 001

object_name: Hepatic impairment


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: Solid Neoplasm


subject: UMLS:C3896776

subject_name: cibisatamab


subject: UMLS:C4721871

subject_name: COX-2 Inhibitor TG01

object_name: non-small cell lung carcinoma


subject: UMLS:C5849104

subject_name: RAS Peptide Cancer Vaccine TG01


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Retinal Pigment Epithelial Detachment


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: kidney failure


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:94366

subject_name: itraconazole

object_name: tinea unguium


subject: UMLS:C5556424

subject_name: Lumrotatug

object_name: plasma cell myeloma


subject: UMLS:C5556424

object_name: adult lymphoma


subject: UMLS:C5556424

object_name: lymphoma


subject: UMLS:C5556424

object_name: pediatric lymphoma


subject: UMLS:C5417840

subject_name: ATR Kinase Inhibitor M1774


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Hypoventilation


subject: CHEBI:36791

object_name: Hypercapnia


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: neoplasm


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: CHEBI:85164


subject: CHEBI:140422

subject_name: VR nerve agent

object_name: Chronic cerebrovascular accident


subject: CHEBI:73711

subject_name: Val-Arg


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Plexosarcoma


subject: UNII:8PQK3QPW4P

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:8PQK3QPW4P

object_name: B-cell neoplasm


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: tick-borne encephalitis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UMLS:C5706486

subject_name: BNT 323

object_name: HER2 positive breast carcinoma


subject: UMLS:C1579314

subject_name: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

object_name: Apnea


subject: UMLS:C1579314

object_name: Apnea, CTCAE


subject: UMLS:C1579314

object_name: Apnea in newborn


subject: UMLS:C1579314

object_name: Premature infant


subject: UMLS:C1579314

object_name: Premature birth


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine